Removal process of prion and parvovirus from human platelet lysates used as clinical-grade supplement for ex vivo cell expansion

Yu Chun Kao, Andy Bailey, Bernhard Samminger, Junji Tanimoto, Thierry Burnouf

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)


Background aims Pooled human platelet lysate (HPL) is becoming the new gold standard as supplement for ex vivo cell culture for clinical protocols. However, the risk of pathogen contamination of HPL increases with the platelet pool size. We hypothesized that hollow fiber anion exchange membrane chromatography using QyuSpeed D (QSD) could remove resistant and untested bloodborne pathogens, such as parvoviruses and prions, from HPL-supplemented growth media without substantially affecting their capacity to support ex vivo cell expansion. Methods Frozen or thawed platelet concentrates were serum-converted and centrifuged for obtaining HPL that was added to various growth media (ca. 100 mL), filtered through a 0.6-mL QSD membrane and characterized for proteins, growth factors and chemical composition. Capacity to expand Chinese hamster ovary, periodontal ligament, gingival fibroblast cells and Wharton's jelly mesenchymal stromal cells was studied. Removal of porcine parvovirus (PPV) and of the 263K prion strain of hamster-adapted scrapie was studied by spiking experiments following international guidelines. Results QSD had minimal impact on HPL-supplemented medium composition in proteins, growth factors and chemical content, nor capacity to expand and differentiate cells. In addition, QSD could remove ≥5.58 log10 [TCID50/mL] and ≥3.72 log10 of PPV and the 263K prion, respectively. Conclusions QSD hollow fiber chromatography can be used to improve the virus and prion safety of HPL-supplemented media to safely expand cells for clinical protocols. These data bring new perspectives for increasingly safer use of pooled HPL in cell therapy and regenerative medicine applications.

Original languageEnglish
Pages (from-to)911-924
Number of pages14
Issue number7
Publication statusPublished - Jul 1 2016


  • cell therapy
  • chromatography
  • hollow fiber
  • membrane
  • platelet lysate
  • prion
  • safety
  • virus

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Oncology
  • Genetics(clinical)
  • Cell Biology
  • Cancer Research
  • Transplantation


Dive into the research topics of 'Removal process of prion and parvovirus from human platelet lysates used as clinical-grade supplement for ex vivo cell expansion'. Together they form a unique fingerprint.

Cite this